Healthcare Management Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with… AIT News Desk May 25, 2022 – Lumasiran Demonstrated Evidence of Improvements in Exploratory Endpoints of Systemic Oxalosis, Including Echocardiographic Structure and…
Healthcare Management Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study… AIT News Desk May 23, 2022 – New Exploratory Findings from 18-Month Analysis of HELIOS-A Suggest that Treatment with Investigational Vutrisiran May Benefit Patients with…
Healthcare Management Alnylam Submits CTA Application For ALN-APP, An Investigational RNAi Therapeutic For The Treatment… AIT News Desk Dec 22, 2021 - Company Expects to Initiate a Phase 1 Study in Early-Onset Alzheimer’s Disease in Early 2022, with Initial Human Data at or Around Year-End 2022 -…
Financial Services Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the… AIT News Desk Apr 13, 2020 Blackstone Provides a Customized Investment at Scale to Enable Alnylam to Achieve Self-Sustainable Financial Profile Without Need for Future Equity…
Big Data Paradigm4 Launches Precision Medicine Platform for UK Biobank Data and Announces Industry-Leading… AIT Staff Writer Nov 27, 2018 The UK Biobank is a groundbreaking international health resource with more than 1.5 petabytes of data planned for collection and analysis: medical…